Publications

Publications published since 2000 or in press from OUS - Department of Nephrology

135 publications found

Publications in press

1. Manner IW, Baekken M, Oektedalen O, Os I
   Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
   Blood Press (in press)
   PubMed 22564000
2. Osthus TB, Preljevic VT, Sandvik L, Leivestad T, Nordhus IH, Dammen T, Os I
   Mortality and health-related quality of life in prevalent dialysis patients: comparison between 12- items and 36-items short-form health survey
   Health Qual Life Outcomes, 10 (1), 46 (in press)
   PubMed 22559816

Publications 2012

1. Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
   Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
   J Acquir Immune Defic Syndr, 59 (2), e24-5
   PubMed 22245717
2. Nordstrand N, Hertel JK, Hofsø D, Sandbu R, Saltvedt E, Røislien J, Os I, Hjelmesæth J (2012)
   A controlled clinical trial of the effect of gastric bypass surgery and intensive lifestyle intervention on nocturnal hypertension and the circadian blood pressure rhythm in patients with morbid obesity
   Surgery, 151 (5), 674-80
   PubMed 22261295
3. Osthus TB, Preljevic V, Sandvik L, Dammen T, Os I (2012)
   Renal transplant acceptance status, health-related quality of life and depression in dialysis patients
   J Ren Care, 38 (2), 98-106
   PubMed 21917125
4. Waldum B, Westheim AS, Sandvik L, Flønæs B, Grundtvig M, Gullestad L, Hole T, Os I (2012)
   Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry
   J Am Coll Cardiol, 59 (4), 371-8
   PubMed 22261159

Publications 2011

1. Fyhrquist F, Silventoinen K, Saijonmaa O, Kontula K, Devereux RB, de Faire U, Os I, Dahlöf B (2011)
   Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study
   J Hum Hypertens, 25 (12), 711-8
   PubMed 21697896
2. Krogvold L, Henrichsen T, Bjerre A, Brackman D, Dollner H, Gudmundsdottir H, Syversen G, Næss PA, Bangstad HJ (2011)
   Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children
   Scand J Trauma Resusc Emerg Med, 19, 44
   PubMed 21798000
3. Nordstrand N, Gjevestad E, Dinh KN, Hofsø D, Røislien J, Saltvedt E, Os I, Hjelmesæth J (2011)
   The relationship between various measures of obesity and arterial stiffness in morbidly obese patients
   BMC Cardiovasc Disord, 11, 7
   PubMed 21284837
4. Os I, Gudmundsdottir H, Draganov B, von der Lippe E (2011)
   Sterile peritonitis associated with amino acid-containing dialysate--a single center experience in Norway
   Perit Dial Int, 31 (1), 103
   PubMed 21282392
5. Preljevic VT, Østhus TB, Sandvik L, Bringager CB, Opjordsmoen S, Nordhus IH, Os I, Dammen T (2011)
   Psychiatric disorders, body mass index and C-reactive protein in dialysis patients
   Gen Hosp Psychiatry, 33 (5), 454-61
   PubMed 21831445
6. Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad F (2011)
   A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8)
   Blood Purif, 32 (3), 151-5
   PubMed 21659742

Publications 2010

1. Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
   Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
   J Acquir Immune Defic Syndr, 53 (3), 419-20
   PubMed 20190590
2. Beitland S, Moen H, Os I (2010)
   Acute kidney injury with renal replacement therapy in trauma patients
   Acta Anaesthesiol Scand, 54 (7), 833-40
   PubMed 20528778
3. Gudmundsdottir H, Taarnhøj NC, Strand AH, Kjeldsen SE, Høieggen A, Os I (2010)
   Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men
   J Hum Hypertens, 24 (8), 505-13
   PubMed 20010619
4. Hedner T, Oparil S, Narkiewicz K, Os I (2010)
   Cardiovascular risks in HIV patients
   Blood Press, 19 (6), 325-7
   PubMed 21080761
5. Manner IW, Baekken M, Oektedalen O, Sandvik L, Os I (2010)
   Effect of HIV duration on ambulatory blood pressure in HIV-infected individuals with high office blood pressure
   Blood Press, 19 (3), 188-95
   PubMed 20482442
6. Norby GE, Lerang K, Holdaas H, Gran JT, Strøm EH, Draganov B, Os I, Hartmann A, Gilboe IM (2010)
   [Lupus-nephritis--diagnosis and treatment]
   Tidsskr Nor Laegeforen, 130 (11), 1140-4
   PubMed 20531500
7. Nordestgaard BG, Kontula K, Benn M, Dahlöf B, de Faire U, Edelman JM, Eliasson E, Fyhrquist F, Hille DA, Ibsen H, Lyle PA, Berg K, Sandberg M, Sethi AA, Wong PH, Os I (2010)
   Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study
   Pharmacogenet Genomics, 20 (2), 77-85
   PubMed 20065889
8. Vervloet M, Bencova V, Malberti F, Ashman N, Os I, Saha H, Ureña P, Zitt E, Rix M, Ryba M, Fouque D, Dehmel B, Petavy F, Jacobson SH (2010)
   >Real-World> use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study
   Clin Nephrol, 74 (3), 198-208
   PubMed 20860904
9. Waldum B, Westheim AS, Sandvik L, Flønaes B, Grundtvig M, Gullestad L, Hole T, Os I (2010)
   Renal function in outpatients with chronic heart failure
   J Card Fail, 16 (5), 374-80
   PubMed 20447572
10. Wiik BP, Larstorp AC, Høieggen A, Kjeldsen SE, Olsen MH, Ibsen H, Lindholm L, Dahlöf B, Devereux RB, Okin PM, Wachtell K (2010)
    Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study
    Am J Hypertens, 23 (8), 845-51
    PubMed 20431530
11. Østhus TB, Dammen T, Sandvik L, Bruun CM, Nordhus IH, Os I (2010)
    Health-related quality of life and depression in dialysis patients: associations with current smoking
    Scand J Urol Nephrol, 44 (1), 46-55
    PubMed 20030569

Publications 2009

1. Baekken M, Os I, Stenehjem A, Sandvik L, Oektedalen O (2009)
   Association between HIV infection and attenuated diurnal blood pressure rhythm in untreated hypertensive individuals
   HIV Med, 10 (1), 44-52
   PubMed 19018875
2. Gabrielli D, Krystal B, Katzarski K, Youssef M, Hachache T, Lopot F, Lasseur C, Gunne T, Draganov B, Wojke R, Gauly A (2009)
   Improved intradialytic stability during haemodialysis with blood volume-controlled ultrafiltration
   J Nephrol, 22 (2), 232-40
   PubMed 19384841
3. Manner I, Sagedal S, Røger M, Os I (2009)
   Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failure
   Clin Nephrol, 72 (3), 224-8
   PubMed 19761730
4. Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S, Rix M, Os I, Saha H, Ryba M, Bencova V, Baños A, Zani V, Fouque D (2009)
   Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study
   Nephrol Dial Transplant, 24 (9), 2852-9
   PubMed 19369690

Publications 2008

1. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
   Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population
   Nephrol Dial Transplant, 23 (10), 3130-7
   PubMed 18469311
2. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
   Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy
   J Hypertens, 26 (11), 2126-33
   PubMed 18854751
3. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M (2008)
   Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study
   Metabolism, 57 (10), 1422-7
   PubMed 18803948
4. Flaa A, Eide IK, Kjeldsen SE, Rostrup M (2008)
   Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study
   Hypertension, 52 (2), 336-41
   PubMed 18574074
5. Gudmundsdottir H, Brørs O, Os I (2008)
   [Metformin should not be used by patients with reduced renal function]
   Tidsskr Nor Laegeforen, 128 (8), 936-7
   PubMed 18431417
6. Gudmundsdottir H, Strand AH, Høieggen A, Reims HM, Westheim AS, Eide IK, Kjeldsen SE, Os I (2008)
   Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty-year follow-up of middle-aged men
   Blood Press, 17 (2), 94-103
   PubMed 18568698
7. Gudmundsdottir H, Strand AH, Kjeldsen SE, Høieggen A, Os I (2008)
   Serum phosphate, blood pressure, and the metabolic syndrome--20-year follow-up of middle-aged men
   J Clin Hypertens (Greenwich), 10 (11), 814-21
   PubMed 19128269
8. Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, Devereux RB, Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators (2008)
   Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy
   Hypertension, 52 (1), 100-6
   PubMed 18504323
9. Os I (2008)
   [Cardiovascular disease in chronic kidney failure]
   Tidsskr Nor Laegeforen, 128 (11), 1297
   PubMed 18546586
10. Os I, Devereux RB, Okin PM (2008)
    Gender differences in left ventricular hypertrophy regression - Response
    Hypertension, 51 (6), E59
11. Os I, Franco V, Kjeldsen SE, Manhem K, Devereux RB, Gerdts E, Hille DA, Lyle PA, Okin PM, Dahlöf B, Oparil S (2008)
    Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study
    Hypertension, 51 (4), 1103-8
    PubMed 18259029
12. Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A (2008)
    Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation
    Nephrol Dial Transplant, 23 (12), 4054-60
    PubMed 18577532
13. Strand A, Kjeldsen SE, Gudmundsdottir H, Os I, Smith G, Bjørnerheim R (2008)
    Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years
    Eur J Echocardiogr, 9 (1), 34-9
    PubMed 17448731

Publications 2007

1. Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE (2007)
   Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
   Metabolism, 56 (11), 1470-7
   PubMed 17950096
2. Jonsson G, Abdelnoor M, Seljeflot I, Arnesen H, Hostmark AT, Kjeldsen SE, Os I, Westheim AS (2007)
   The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients
   J Cardiovasc Pharmacol, 49 (1), 27-32
   PubMed 17261960
3. Kjeldsen SE, Lyle PA, Kizer JR, Oparil S, Høieggen A, Os I (2007)
   Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke
   Vasc Health Risk Manag, 3 (3), 299-305
   PubMed 17703637
4. Nordal EJ, Os I (2007)
   [Uremic pruritus--pathogenesis and treatment]
   Tidsskr Nor Laegeforen, 127 (9), 1201-3
   PubMed 17479139
5. Singer JB, Holdaas H, Jardine AG, Fellstrøm B, Os I, Bermann G, Meyer JM, Assessment of Lescol in Renal Transplantation (ALERT) Study Investigators (2007)
   Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients
   J Lipid Res, 48 (9), 2072-8
   PubMed 17563401
6. Smebye ML, Iversen EK, Høieggen A, Flaa A, Os I, Kjeldsen SE, Olsen MH, Chattopadhyay A, Hille DA, Lyle PA, Devereux RB, Dahlöf B (2007)
   Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study)
   Am J Cardiol, 100 (5), 855-9
   PubMed 17719333
7. Stenehjem AE, Bjørnerheim R, Os I (2007)
   From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion
   Blood Press, 16 (2), 87-94
   PubMed 17612906
8. Stenehjem AE, Vahter M, Nermell B, Aasen J, Lierhagen S, Mørland J, Jacobsen D (2007)
   Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercaptosuccinic acid)
   Clin Toxicol (Phila), 45 (4), 424-8
   PubMed 17486487
9. Strand A, Gudmundsdottir H, Høieggen A, Fossum E, Bjørnerheim R, Os I, Kjeldsen SE (2007)
   Increased hematocrit before blood pressure in men who develop hypertension over 20 years
   J Am Soc Hypertens, 1 (6), 400-6
   PubMed 20409872
10. Strand AH, Gudmundsdottir H, Fossum E, Os I, Bjørnerheim R, Kjeldsen SE (2007)
    Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years
    J Clin Hypertens (Greenwich), 9 (5), 365-71
    PubMed 17485972
11. Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007)
    Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes
    Transplantation, 83 (5), 600-6
    PubMed 17353781

Publications 2006

1. Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE (2006)
   Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors
   J Hum Hypertens, 20 (11), 860-6
   PubMed 16988754
2. Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M (2006)
   Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges
   Hypertension, 47 (3), 396-402
   PubMed 16446389
3. Fossum E, Olsen MH, Høieggen A, Wachtell K, Reims HM, Kjeldsen SE, Ibsen H, Wan Y, Julius S (2006)
   Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy
   J Clin Hypertens (Greenwich), 8 (3), 169-73
   PubMed 16522993
4. Gudmundsdottir H, Aksnes H, Heldal K, Krogh A, Froyshov S, Rudberg N, Os I (2006)
   Metformin and antihypertensive therapy with drugs blocking the renin angiotensin system, a cause of concern?
   Clin Nephrol, 66 (5), 380-5
   PubMed 17140168
5. Hartmann A, Holdaas H, Os I, Hunderi OH, Hallan S, Widerøe TE, Svarstad E, Selvig K, Skjønsberg H, Toft I (2006)
   [Staging and measurement of renal function in chronic renal conditions]
   Tidsskr Nor Laegeforen, 126 (9), 1198-200
   PubMed 16670740
6. Jonsson G, Abdelnoor M, Landaas S, Muller C, Kjeldsen SE, Os I, Westheim A (2006)
   N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy
   Cardiology, 106 (2), 102-8
   PubMed 16636540
7. Narayan P, Papademetriou V, Wachtell K, Gerdts E, Boman K, Nieminen MS, de Simone G, Dahlöf B, Fyhrquist F, Hoieggen A, Devereux RB (2006)
   Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study
   Hypertension, 47 (5), 868-73
   PubMed 16567586
8. Oien CM, Reisaeter AV, Os I, Jardine A, Fellström B, Holdaas H (2006)
   Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study
   Clin Transplant, 20 (3), 374-82
   PubMed 16824157
9. Os I (2006)
   Comparison of doxazosin GITS and standard doxazosin in the treatment of high blood pressure
   Int J Clin Pharmacol Ther, 44 (3), 99-106
   PubMed 16550731
10. Os I, Gudmundsdottir H, Kjeldsen SE, Oparil S (2006)
    Treatment of isolated systolic hypertension in diabetes mellitus type 2
    Diabetes Obes Metab, 8 (4), 381-7
    PubMed 16776744
11. Raeder H, Bjørkhaug L, Johansson S, Mangseth K, Sagen JV, Hunting A, Følling I, Johansen O, Bjørgaas M, Paus PN, Søvik O, Molven A, Njølstad PR (2006)
    A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry
    Diabetes, 55 (6), 1899-903
    PubMed 16731861
12. Reikvam A, Hexeberg S, Kvien TK, Slørdal L, Aabakken L, Engebretsen L, Flatø B, Idsø N, Johnsen V, Kalstad S, Madsen S, Mikkelsen K, Os I, REder J (2006)
    [Clinical use of COX inhibitors--a consensus]
    Tidsskr Nor Laegeforen, 126 (5), 591-5
    PubMed 16505867
13. Stenehjem AE, Gudmundsdottir H, Os I (2006)
    Office blood pressure measurements overestimate blood pressure control in renal transplant patients
    Blood Press Monit, 11 (3), 125-33
    PubMed 16702821
14. Stenehjem AE, Os I (2006)
    Clinical utility and applicability of smoothness index, normalized smoothness index and individualized RDH index during treatment of essential hypertension
    Blood Press, 15 (5), 281-90
    PubMed 17380846
15. Strand AH, Gudmundsdottir H, Os I, Smith G, Westheim AS, Bjørnerheim R, Kjeldsen SE (2006)
    Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years
    J Hypertens, 24 (5), 905-13
    PubMed 16612253
16. Tonstad S, Klemsdal TO, Landaas S, Høieggen A (2006)
    No effect of increased water intake on blood viscosity and cardiovascular risk factors
    Br J Nutr, 96 (6), 993-6
    PubMed 17181872

Publications 2005

1. Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM (2005)
   The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis
   Maturitas, 52 (2), 111-8
   PubMed 16186073
2. Hovda KE, Froyshov S, Gudmundsdottir H, Rudberg N, Jacobsen D (2005)
   Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases
   Clin Nephrol, 64 (3), 190-7
   PubMed 16175943
3. Høieggen A, Os I, Kjeldsen SE (2005)
   [Uric acid--more deleterious than we thought?]
   Tidsskr Nor Laegeforen, 125 (10), 1330-2
   PubMed 15909004
4. Jonsson G, Abdelnoor M, Müller C, Kjeldsen SE, Os I, Westheim A (2005)
   A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients
   Cardiology, 103 (3), 148-55
   PubMed 15785019
5. Kjeldsen SE, Os I, Høieggen A, Beckey K, Gleim GW, Oparil S (2005)
   Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide
   Am J Cardiovasc Drugs, 5 (1), 17-22
   PubMed 15631534
6. Kjeldsen SE, Westheim AS, Os I (2005)
   More heat to support aggressive blood pressure lowering: the FEVER study
   J Hypertens, 23 (12), 2145-6
   PubMed 16269953
7. Kjeldsen SE, Westheim AS, Os I (2005)
   Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: LIFE, SCOPE, and VALUE
   Curr Hypertens Rep, 7 (3), 155-7
   PubMed 15913486
8. Olsen MH, Fossum E, Høieggen A, Wachtell K, Hjerkinn E, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S (2005)
   Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy
   J Hypertens, 23 (4), 891-8
   PubMed 15775796
9. Os I (2005)
   [PPARgamma agonists--antidiabetics with positive effects on cardiovascular risk?]
   Tidsskr Nor Laegeforen, 125 (21), 2929-31
   PubMed 16276373
10. Os I, Os A, Abdelnoor M, Larsen A, Birkeland K, Westheim A (2005)
    Insulin sensitivity in women with coronary heart disease during hormone replacement therapy
    J Womens Health (Larchmt), 14 (2), 137-45
    PubMed 15775731
11. Prøsch LK, Saelen MG, Gudmundsdottir H, Dyrbekk D, Hunderi OH, Arnesen E, Paulsen D, Skjønsberg H, Os I (2005)
    Blood pressure control is hard to achieve in patients with chronic renal failure: results from a survey of renal units in Norway
    Scand J Urol Nephrol, 39 (3), 242-8
    PubMed 16127803
12. Reims HM, Sevre K, Fossum E, Mellem H, Eide IK, Kjeldsen SE (2005)
    Adrenaline during mental stress in relation to fitness, metabolic risk factors and cardiovascular responses in young men
    Blood Press, 14 (4), 217-26
    PubMed 16126555
13. Reims HM, Sevre K, Høieggen A, Fossum E, Eide I, Kjeldsen SE (2005)
    Blood viscosity: effects of mental stress and relations to autonomic nervous system function and insulin sensitivity
    Blood Press, 14 (3), 159-69
    PubMed 16036496
14. Saelen MG, Prøsch LK, Gudmundsdottir H, Dyrbekk D, Helge Hunderi O, Arnesen E, Paulsen D, Skjønsberg H, Os I (2005)
    Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function
    Blood Press, 14 (3), 170-6
    PubMed 16036497
15. Tomson J, Os I, Lip GY (2005)
    Hormone replacement use and cardiovascular function and structure in postmenopausal women
    Blood Press, 14 (1), 3-5
    PubMed 15823940
16. Øien CM, Reisaeter AV, Leivestad T, Pfeffer P, Fauchald P, Os I (2005)
    Gender imbalance among donors in living kidney transplantation: the Norwegian experience
    Nephrol Dial Transplant, 20 (4), 783-9
    PubMed 15701672

Publications 2004

1. Fossum E, Høieggen A, Reims HM, Moan A, Rostrup M, Eide I, Kjeldsen SE (2004)
   High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men
   Blood Press, 13 (2), 89-94
   PubMed 15182111
2. Fossum E, Olsen MH, Høieggen A, Wachtell K, Reims HM, Ibsen H, Julius S, Kjeldsen SE (2004)
   Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy
   J Hum Hypertens, 18 (6), 375-80
   PubMed 15057253
3. Høieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B, LIFE Study Group (2004)
   The impact of serum uric acid on cardiovascular outcomes in the LIFE study
   Kidney Int, 65 (3), 1041-9
   PubMed 14871425
4. Kjeldsen SE, Os I, Hedner T, Himmelmann A (2004)
   Renal hypertensive target organ damage--new evidence emerges in diabetics and smokers
   Blood Press, 13 (6), 324-5
   PubMed 15771214
5. Os I, Landmark K, Toft I (2004)
   [Can hydrochlorothiazide and chlorthalidone be compared in the treatment of hypertension?]
   Tidsskr Nor Laegeforen, 124 (6), 829
   PubMed 15039824
6. Os I, Oparil S, Gerdts E, Høieggen A (2004)
   Essential hypertension in women
   Blood Press, 13 (5), 272-8
   PubMed 15545149
7. Reims HM, Fossum E, Høieggen A, Moan A, Eide I, Kjeldsen SE (2004)
   Adrenal medullary overactivity in lean, borderline hypertensive young men
   Am J Hypertens, 17 (7), 611-8
   PubMed 15233980
8. Reims HM, Sevre K, Fossum E, Høieggen A, Eide I, Kjeldsen SE (2004)
   Plasma catecholamines, blood pressure responses and perceived stress during mental arithmetic stress in young men
   Blood Press, 13 (5), 287-94
   PubMed 15545152
9. Reims HM, Sevre K, Fossum E, Høieggen A, Mellem H, Kjeldsen SE (2004)
   Relations between insulin sensitivity, fitness and autonomic cardiac regulation in healthy, young men
   J Hypertens, 22 (10), 2007-15
   PubMed 15361774
10. Stenehjem AE, Os I (2004)
    Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension
    Blood Press, 13 (4), 214-24
    PubMed 15581335

Publications 2003

1. Höieggen A, Fossum E, Reims H, Kjeldsen SE (2003)
   Serum uric acid and hemorheology in borderline hypertensives and in subjects with established hypertension and left ventricular hypertrophy
   Blood Press, 12 (2), 104-10
   PubMed 12797630
2. Kjeldsen SE, Fossum E, Reims HM, Høieggen A (2003)
   Hypertension treatment and stroke prevention
   Blood Press, 12 (5-6), 264-8
   PubMed 14763656
3. Kjeldsen SE, Os I (2003)
   Hypertension in very old people
   J Hypertens, 21 (12), 2249-50
   PubMed 14654743
4. Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T (2003)
   C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
   Transplantation, 76 (8), 1236-8
   PubMed 14578761
5. Olsen MH, Hjerkinn E, Wachtell K, Høieggen A, Bella JN, Nesbitt SD, Fossum E, Kjeldsen SE, Julius S, Ibsen H (2003)
   Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy
   J Hum Hypertens, 17 (5), 305-11
   PubMed 12756402
6. Os I (2003)
   [COX-2 inhibitors and their effects on kidney and blood pressure]
   Tidsskr Nor Laegeforen, 123 (10), 1339-41
   PubMed 12806672
7. Os I, Fredheim CS, Draganov B, Høieggen A, Andersson KS (2003)
   [Acute renal failure during the treatment of heart failure with ACE inhibitors]
   Tidsskr Nor Laegeforen, 123 (1), 30-2
   PubMed 12600146
8. Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland K, Westheim A (2003)
   Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
   J Intern Med, 253 (2), 232-9
   PubMed 12542565
9. Os I, Os A, Abdelnoor M, Larsen A, Birkeland K, Westheim A (2003)
   Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate
   Climacteric, 6 (3), 204-10
   PubMed 14567768
10. Os I, Toft I (2003)
    [Thiazides in the treatment of hypertension]
    Tidsskr Nor Laegeforen, 123 (15), 2100-1
    PubMed 12934147
11. Podzolkov VI, Bulatov VA, Son EA, Os I (2003)
    Central and peripheral hemodynamic effects of losartan and in combination with hydrochlorothiazide in mild to moderate essential hypertension
    Blood Press, 12 (4), 239-45
    PubMed 14596361

Publications 2002

1. Jonsson G, Fossum E, Kjeldsen SE, Høieggen A, Os I, Eide I, Westheim A (2002)
   Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction
   Blood Press, 11 (6), 377-84
   PubMed 12523682
2. Os I (2002)
   [Sex differences in the risk for coronary heart disease]
   Tidsskr Nor Laegeforen, 122 (22), 2225
   PubMed 12426905
3. Os I, Djurovic S, Seljeflot I, Berg K (2002)
   Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1?
   J Intern Med, 251 (3), 223-7
   PubMed 11886481
4. Os I, Os A, Sandset PM, Bølling S, Seljeflot I, Djurovic S, Westheim A (2002)
   Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine
   Cardiology, 98 (1-2), 6-12
   PubMed 12373040
5. Os I, Stenehjem A, Høieggen A, Draganov B, Jenssen T, Holdaas H (2002)
   [Type 2 diabetes and nephropathy--new studies, new treatment strategies?]
   Tidsskr Nor Laegeforen, 122 (9), 918-20
   PubMed 12082835
6. Os I, Tonstad S (2002)
   [Hormone replacement therapy in menopause and cardiovascular disease--one more time]
   Tidsskr Nor Laegeforen, 122 (18), 1808-10
   PubMed 12362695

Publications 2001

1. Boulatov VA, Stenehjem A, Os I (2001)
   Association between albumin:creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension
   Am J Hypertens, 14 (4 Pt 1), 338-44
   PubMed 11336179
2. Bulatov VA, Stenehjem A, Os I (2001)
   Left ventricular mass assessed by electrocardiography and albumin excretion rate as a continuum in untreated essential hypertension
   J Hypertens, 19 (8), 1473-8
   PubMed 11518856
3. Fossum E, Berge KE, Høieggen A, Moan A, Rostrup M, Kjeldsen SE, Eide I, Berg K (2001)
   Polymorphisms in candidate genes for blood pressure regulation in young men with normal or elevated screening blood pressure
   Blood Press, 10 (2), 92-100
   PubMed 11467765
4. Høieggen A, Draganov B, Os I (2001)
   [Bilateral renal artery stenosis--a cause of acute pulmonary edema]
   Tidsskr Nor Laegeforen, 121 (15), 1789-90
   PubMed 11464682
5. Høieggen A, Fossum E, Moan A, Rostrup M, Eide IK, Kjeldsen SE (2001)
   Biphasic effect of epinephrine on blood glucose during hyperinsulinemia in borderline hypertensive young men
   Am J Hypertens, 14 (6 Pt 1), 539-45
   PubMed 11411733
6. Kløw NE, Draganov B, Os I (2001)
   [Metformin and contrast media--increased risk of lactic acidosis?]
   Tidsskr Nor Laegeforen, 121 (15), 1829
   PubMed 11464691
7. Os I, Ström EH, Stenehjem A, Gudmundsdottir H, Langberg H, Draganov B, Godøy J, Dunlop O, von der Lippe B (2001)
   Varicella infection in a renal transplant recipient associated with abdominal pain, hepatitis, and glomerulonephritis
   Scand J Urol Nephrol, 35 (4), 330-3
   PubMed 11676362
8. Reims HM, Høieggen A, Fossum E, Rostrup M, Eide I, Kjeldsen SE (2001)
   Glucose disposal rates calculated from 60- to 90-minute isoglycemic hyperinsulinemic glucose clamp correlate with cardiovascular risk factors in borderline hypertensive young men
   Metabolism, 50 (10), 1175-80
   PubMed 11586489
9. Ross AE, Flaa A, Høieggen A, Reims H, Eide IK, Kjeldsen SE (2001)
   Gender specific sympathetic and hemorrheological responses to mental stress in healthy young subjects
   Scand Cardiovasc J, 35 (5), 307-12
   PubMed 11771821
10. Sevre K, Lefrandt JD, Nordby G, Os I, Mulder M, Gans RO, Rostrup M, Smit AJ (2001)
    Autonomic function in hypertensive and normotensive subjects: the importance of gender
    Hypertension, 37 (6), 1351-6
    PubMed 11408376
11. Stenehjem AE, Bulatov VA, Os I (2001)
    [24-hour blood pressure monitoring and albumin excretion in urine in hypertension]
    Tidsskr Nor Laegeforen, 121 (15), 1806-10
    PubMed 11464686

Publications 2000

1. Belki? K, Schwartz J, Schnall P, Pickering TG, Steptoe A, Marmot M, Theorell T, Fossum E, Høieggen A, Moan A, Rostrup M, Kjeldsen SE (2000)
   Evidence for mediating econeurocardiologic mechanisms
   Occup Med, 15 (1), 117-62
   PubMed 10620789
2. Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Hjermann I, Jenssen T, Jervell J, Os I (2000)
   [Prevention of cardiovascular disease in type 2 diabetes]
   Tidsskr Nor Laegeforen, 120 (21), 2554-9
   PubMed 11070996
3. Djurovic S, Os I, Hofstad AE, Abdelnoor M, Westheim A, Berg K (2000)
   Increased plasma concentrations of TGF-beta1 after hormone replacement therapy
   J Intern Med, 247 (2), 279-85
   PubMed 10692092
4. Hoibraaten E, Os I, Seljeflot I, Andersen TO, Hofstad A, Sandset PM (2000)
   The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study
   Thromb Res, 98 (1), 19-27
   PubMed 10706930
5. Høieggen A, Fossum E, Moan A, Rostrup M, Eide IK, Kjeldsen SE (2000)
   Effects of hyperinsulinemia on sympathetic responses to mental stress
   Am J Hypertens, 13 (1 Pt 1), 21-8
   PubMed 10678267
6. Høieggen A, Fossum E, Nesbitt SD, Palmieri V, Kjeldsen SE (2000)
   Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica
   Blood Press, 9 (2-3), 83-90
   PubMed 10855729
7. Kjeldsen SE, Os I, Farsang C, Mallion JM, Hansson L, Sleight P (2000)
   Treatment of hypertension in patients with type-2 diabetes mellitus
   J Hypertens, 18 (9), 1345-6
   PubMed 10994767
8. Kjeldsen SE, Os I, Farsang C, Mallion JM, Hansson L, Sleight P (2000)
   Treatment of hypertension in patients with type-2 diabetes mellitus
   Blood Press, 9 (6), 363-4
   PubMed 11212066
9. Kjeldsen SE, Westheim AS, Os I (2000)
   INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study
   Lancet, 356 (9245), 1929-30
   PubMed 11130406
10. Olsen MH, Fossum E, Hjerkinn E, Wachtell K, Høieggen A, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S (2000)
    Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia
    J Hypertens, 18 (1), 75-81
    PubMed 10678546
11. Os I, Hofstad AE, Brekke M, Abdelnoor M, Nesheim BI, Jacobsen AF, Birkeland K, Larsen A, Midtbo K, Westheim A (2000)
    The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
    J Intern Med, 247 (4), 433-41
    PubMed 10792556
12. Reims H, Høieggen A, Fossum E, Kjeldsen SE (2000)
    Assessment of insulin sensitivity by 90 min isoglycaemic hyperinsulinaemic glucose clamp in healthy young men
    Blood Press, 9 (2-3), 121-5
    PubMed 10855735
13. Seljeflot I, Arnesen H, Hofstad AE, Os I (2000)
    Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease
    Thromb Haemost, 83 (6), 944-8
    PubMed 10896253
14. Tonstad S, Os I (2000)
    [Does postmenopausal hormone replacement therapy have a place in treatment of hyperlipidemia?]
    Tidsskr Nor Laegeforen, 120 (8), 923-6
    PubMed 10795496